“showed a trend”

Interestingly, the lower sensitivity of AA (indicated by higher TOT) compared to VV is accompanied by a higher variability of PSS scores and TOT (Levene’s test suggests that the assumption of equal variance for the TOT between the AA and VV conditions could not be supported: AA > VV: F = 4.5, p = 0.04; the differences in the PSS scores showed a trend in the same direction: AA > VV: F = 3.2, p = 0.08; see Figure 2 ) between participants in AA compared to VV which is also consistent with the study by Zampini et al.

ChAdOx1 using lpCMV elicited the most potent cellular responses (mean ≈5000 SFC/10 6 PBMCs), significantly higher than those elicited by cSE4 ( p < 0.005) and showed a trend toward greater magnitude than cSE5 ( p = 0.08).

Uncorrected results showed a trend towards differing reaction time on the WMT ( t (45) = 1.8, p = 0.08).

Sensitivity also showed a trend toward superiority for DL (0.77 vs 0.68, P = 0.08).

This finding was primarily associated with candidemia, which also showed a trend towards increased 30‐day mortality ( p = 0.08), as well as with septic shock, peritonitis, and prior antibiotic use.

In an analysis of covariance, BMI and age were not associated with impaired compensation after nephrectomy (absolute and relative ΔeGFR for BMI: P = 0.44 and P = 0.68; and for age: P = 0.78 and P = 0.56); individuals with VO showed a trend toward greater ΔeGFR ( P = 0.08), whereas the association in relative ΔeGFR was not statistically robust ( P = 0.14).

In models incorporating time‐updated diameter, ATAA size remained associated with all‐cause mortality (HR, 1.43 [95% CI, 1.15–1.77]; P = 0.001) and showed a trend toward association with aortic‐specific mortality (HR, 1.46 [95% CI, 0.96–2.21]; P = 0.08) (Table 3 ).

Pooled data from these 6 trials showed a trend to low cardiac death vs. the comparator p = 0.08 in favor ( Figure 1 ) but a significant increase of non-cardiac death in the DES vs. comparator arm (5.5% vs. 3.8%, respectively, p = 0.000018) in favor to comparator Figure 2 .

Complex karyotype showed a trend toward inferior outcomes (3-y OS: 37.5% vs. 65.1%, p = 0.08, 3-y PFS: 31.3% vs. 54.2%, p = 0.08).

LS greater than 6 Kpa at day +14 also showed a trend toward worse OS (asHR: 2.3, 95% CI 0.9–6.0; p=0.08).

ROI-specific Welch t-tests showed a trend toward reduced tNAA in the left motor cortex (p≈0.08; Cohen’s d ≈ 0.67), with a smaller difference in the right motor cortex (p≈0.27).

The comprehension subscale also showed a trend toward a between-group difference ( p = 0.080).

However, patients treated with SIRO experienced significantly fewer hospitalizations (IRR 0.47; 95% CI 0.23–0.94; p = 0.03) and showed a trend toward fewer relapses (IRR 0.57; 95% CI 0.31–1.06; p = 0.08).

On withdrawal day 15, both CIE-KD and CIE-KE showed a trend ( p = 0.08 and p = 0.07 vs.

Similarly, the exercise group showed a trend toward lower levels of IL-6 compared to the control group only in female placentas ( B = −0.60, SE = 0.34, p = 0.08).

However, the survival disadvantage associated with high NTRK1 was statistically significant in females (p=0.005) but only showed a trend in males (p=0.08), likely due to the smaller sample size of the male cohort.

The BP ND in striatum one week after discontinuation showed a trend towards lower values in patients who remained stable (mean: 3.35, SD 0.89) than in those who relapsed (mean 3.82, SD 0.65) ( t = -1.789, p = 0.080, CI = -0.983 to 0.058).

The change from testing in Context B to Context A was not statistically significant but showed a trend, t (14) = −1.89, p = 0.080, d = −0.48 (medium).

The Kaplan–Meier analysis showed a trend toward a difference between conservative and radical surgery (p=0.08).

Pro-apoptotic BCL2 associated X protein ( Bax ) had significantly increased expression in ovaries from offspring originating from PCEtOH-exposed pregnancies, while the pro-survival B cell leukemia/lymphoma 2 ( Bcl2 ) gene showed a trend ( p < 0.08) for increased expression.

MMP-7 significantly outperformed APRI (AUC = 0.749, p = 0.045) and showed a trend toward superiority over FIB-4 (AUC = 0.759, p = 0.080) ( Figure 3A ).

Post hoc analysis for the drug × genotype interaction showed a trend for an effect of genotype in the S‐ket group ( p = .08), with KO mice showing reduced time in the open arm/closed arm.

Analysis of the frequency of achieving maximal safe resection (≥95% of tumor volume) showed a trend toward higher rates in the IOUS group (62.2% vs. 44.4%, P = 0.08).

9.6 months, p=0.02), while stage IIB showed a trend towards improved OS (63.6 vs. 25.9 months, p=0.08).

When stratified by cancer type, early-onset Hispanic/Latino patients with colon adenocarcinoma showed a trend toward marginal significance in WNT pathway alterations compared to early-onset NHW patients (93.3% vs. 69%, p = 0.08), suggesting potential ethnic-specific variations in this pathway for colon cancer ( Table S4 ).